Study on pleiotropic effects of angiotensin II- receptor blockers (ARB) in hypertensive obese patients.
Not Applicable
Completed
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000000469
- Lead Sponsor
- 3M STUDY GROUP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
-patients with secondary hypertension -patients whose AST or ALT exceeding 100IU/L -patients with bile stenosis -patients with severe renal failure or nephrotic syndrome -patients with severe cerebral infarction -pregnant women or those who plan pregnancy, or in the lactation period -patients with neoplasm -patients with history of hypersensitivity to telmisartan, valsartan, or candesartan -other patients judged unsuitable for the study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method